These findings have important implications for selecting and testing directed therapeutic options for persons with DA2A and perhaps congenital contractures in general.
Recently, mutations in MYH3 were demonstrated to be associated with congenital joint contractures, that is, Freeman-Sheldon and Sheldon-Hall syndromes, which are both distal arthrogryposis syndromes.